The cost-effectiveness of OZURDEX® (dexamethasone intravitreal implant in applicator) compared with observation for the treatment of macular oedema following central and branch retinal vein occlusion

 

Publication Type:
Poster


Citation:

Hayward E, Almond C, Trueman D, Yeh W-S and Kowalski JW. The cost-effectiveness of OZURDEX® (dexamethasone intravitreal implant in applicator) compared with observation for the treatment of macular oedema following central and branch retinal vein occlusion. 14th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress Madrid, Spain. 5-8 November 2011. Poster PSS25.

 


Link to publication ⟶

⟵ Back to Search Results